{"id":"NCT02822508","sponsor":"Braintree Laboratories","briefTitle":"A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation","officialTitle":"A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-06","primaryCompletion":"2017-04","completion":"2017-04","firstPosted":"2016-07-04","resultsPosted":"2023-11-07","lastUpdate":"2023-11-07"},"enrollment":434,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Constipation"],"interventions":[{"type":"DRUG","name":"BLI801 Laxative","otherNames":[]},{"type":"DRUG","name":"BLI801 Placebo","otherNames":[]}],"arms":[{"label":"BLI801 Laxative (high dose)","type":"EXPERIMENTAL"},{"label":"BLI801 Laxative (mid dose)","type":"EXPERIMENTAL"},{"label":"BLI801 Laxative (low dose)","type":"EXPERIMENTAL"},{"label":"BLI801 Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.","primaryOutcome":{"measure":"% of Subjects With Treatment Response","timeFrame":"12 weeks","effectByArm":[{"arm":"BLI801 Laxative (High Dose)","deltaMin":42,"sd":null},{"arm":"BLI801 Laxative (Mid Dose)","deltaMin":34,"sd":null},{"arm":"BLI801 Laxative (Low Dose)","deltaMin":30,"sd":null},{"arm":"BLI801 Placebo","deltaMin":20,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002 vs OG003","p":"0.034"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":73,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":114},"commonTop":["Urinary tract infection","Diarrhoea","Flatulence","Abdominal pain","Abdominal distension"]}}